CN101933982B - Capsule for treating rectitis - Google Patents

Capsule for treating rectitis Download PDF

Info

Publication number
CN101933982B
CN101933982B CN2010102888508A CN201010288850A CN101933982B CN 101933982 B CN101933982 B CN 101933982B CN 2010102888508 A CN2010102888508 A CN 2010102888508A CN 201010288850 A CN201010288850 A CN 201010288850A CN 101933982 B CN101933982 B CN 101933982B
Authority
CN
China
Prior art keywords
parts
rectitis
capsule
proctitis
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010102888508A
Other languages
Chinese (zh)
Other versions
CN101933982A (en
Inventor
赵军海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102888508A priority Critical patent/CN101933982B/en
Publication of CN101933982A publication Critical patent/CN101933982A/en
Application granted granted Critical
Publication of CN101933982B publication Critical patent/CN101933982B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a medicament for treating rectitis, in particular to a capsule for treating rectitis, which solves the problem that rectitis cannot be completely cured by the conventional rectitis treatment method. The capsule for treating rectitis is prepared from the following raw materials in part by weight: 1.25 to 2.5 parts of phenolphthalein, 1 to 2 parts of vitamin B1, 5 to 10 parts of metronidazole, 3 to 50 parts of rhubarb and 3 to 50 parts of cinnamon. The raw materials are combined with one another and facilitate one another. The capsule has the effects of rapidly relieving, eliminating symptom and dispelling rectitis as well as the advantages of addressing both of the symptoms and root causes, unique curative effect and no toxic or side effect.

Description

The proctitis capsule
Technical field
The present invention relates to treat the medicine of proctitis, be specially a kind of proctitis capsule.
Background technology
Proctitis is a unremarkable disease, is but perplexing countries in the world doctor and patient's great attention, and it is pertinacious disease that the doctor looks proctitis, and it is the serious illness that the patient looks proctitis.Traditional therapy is single medication, antiinflammatory, laxation, loosening bowel to relieve constipation; Relief of symptoms that can only be temporary transient but can not thoroughly be cured, and obeys a kind of medicine for a long time, and not only drug effect reduces; But also can influence patient's gastrointestinal function, and make patient be absorbed in worry extremely, sorrow, even increase the weight of the state of an illness.
Summary of the invention
The problem that the present invention can not thoroughly cure for the Therapeutic Method that solves existing proctitis provides a kind of proctitis capsule.
The present invention adopts following technical scheme to realize: the proctitis capsule, process by the raw material of following parts by weight: phenolphthalein 1.25-2.5 part, vitamin B1 1-2 part, metronidazole 5-10 part, Radix Et Rhizoma Rhei 3-50 part, Cortex Cinnamomi 3-50 part.This medicine is that the constipation, the tenesmus that are directed against proctitis have better therapeutic effect.
The proctitis capsule is processed by the raw material of following parts by weight: 2.5 parts of phenolphthaleins, 2 parts of vitamin B1s, 10 parts of metronidazoles, 50 parts of Radix Et Rhizoma Rhei, 50 parts of Cortex Cinnamomis.The formula proportion of this medicine can further be strengthened the therapeutic effect of proctitis.
Said medicine adopts traditional processing method, clays into power Chinese medicine with pulverizer,, incapsulates every heavy 1.5 grams with Western medicine powder mixing.
Medicine of the present invention is a capsule, and content is yellowish white powder, mildly bitter flavor.Points for attention: 1, metronidazole allergy sufferers forbidding, 2, the careful usefulness of the bad person of stomach function.
In the said medicine: phenolphthalein: having stimulates intestinal wall to promote the effect of wriggling, mainly acts on colon, and the catharsis effect is gentle; Vitamin B1: be white crystals or crystalline powder, have faint special smellyly that bitter in the mouth is mainly used in polyneuritis, peripheral neuritis, central nervous system injury, malnutrition; Metronidazole: be white or little yellow crystal or crystalline powder; Have little smelly; Bitter in the mouth and slightly salty; Clinical being mainly used in prevented and the microbial infection of treatment anaerobism; Infect like respiratory tract, digestive tract, abdominal cavity and basin pus, the endocarditis that the infection at positions such as skin soft tissue, bone and osteoarthrosis and bacteroides fragilis cause, septicemia and meningitis etc. are widely used in prevention in addition and the treatment oral cavity anaerobium infects; Radix Et Rhizoma Rhei: bitter in the mouth, cold in nature, it is cold purgatives medicine, and the constipation with heat retention that can the bowel relieving sthenia gastropyrexia gathers is dredged the intestines and stomach, and the effect tied is gone in relieving constipation; Cortex Cinnamomi: acrid-sweet flavor, extremely hot in nature has the effect of YANG invigorating dispersing cold for relieving pain, is good at warm promoting blood circulation.
All medicine combinations are used, and mutually promote, and have rapid alleviation, eliminate symptom, dispel the effect of proctitis, and treating both the principal and secondary aspects of a disease, special effect, without any side effects.Through 86 patients are treated, statistical result is: medicine according to the invention can reach more than 98% the effective percentage of treatment proctitis disease, and cure rate can reach more than 95%.
Model case
1, Mrs Li, 27 years old, surplus the readme 10 year before, suffer from proctitis, constipation, invalid through multi-treatment, after upon somebody's introduction, take medicine of the present invention, four days transference cures were consolidated curative effect in seven days, followed up a case by regular visits to after 1 year, violated so far.
2, Ms Zhang: 37 years old, take medicine of the present invention after four days, constipation for many years disappears, and obeys and consolidates its curative effect in four days, thoroughly cures.
3, Mr. Wang, 40 years old, the proctitis constipation in 20 years, very painful, take medicine of the present invention, thoroughly cured after seven days.
4, Mrs Li, 50 years old, suffer from proctitis, tenesmus, day row repeatedly, each defecation is not smooth, takes medicine of the present invention transference cure after five days, does not see recurrence so far.
5, Mr. Guo, 21 years old, suffered from proctitis 5 years, every day, defecation was 4-6 time, took medicine of the present invention transference cure after four days, and the clothes four days of continuing are consolidated its curative effect, so far criminal.
The specific embodiment
Embodiment 1:
The proctitis capsule, process by the raw material (every part 1 gram) of following parts by weight: phenolphthalein: 1.5 parts, vitamin B1: 1 part, metronidazole: 8 parts, Radix Et Rhizoma Rhei: 28 grams, Cortex Cinnamomi: 37 grams.
Said medicine adopts traditional processing method, clays into power Chinese medicine with pulverizer,, incapsulates every heavy 1.5 grams with Western medicine powder mixing.
Embodiment 2
The proctitis capsule, process by the raw material (every part 1 gram) of following parts by weight: phenolphthalein: 2 parts, vitamin B1: 1.8 parts, metronidazole: 6 parts, Radix Et Rhizoma Rhei: 18 grams, Cortex Cinnamomi: 45 grams.
Said medicine adopts traditional processing method, clays into power Chinese medicine with pulverizer,, incapsulates every heavy 1.5 grams with Western medicine powder mixing.
Embodiment 3
The proctitis capsule, process by the raw material (every part 1 gram) of following parts by weight: phenolphthalein: 2.5 parts, vitamin B1: 2 parts, metronidazole: 10 parts, Radix Et Rhizoma Rhei: 50 grams, Cortex Cinnamomi: 50 grams.
Said medicine adopts traditional processing method, clays into power Chinese medicine with pulverizer,, incapsulates every heavy 1.5 grams with Western medicine powder mixing.
Embodiment 4
The proctitis capsule, process by the raw material (every part 1 gram) of following parts by weight: phenolphthalein: 2.1 parts, vitamin B1: 1.3 parts, metronidazole: 7 parts, Radix Et Rhizoma Rhei: 8 grams, Cortex Cinnamomi: 11 grams.
Said medicine adopts traditional processing method, clays into power Chinese medicine with pulverizer,, incapsulates every heavy 1.5 grams with Western medicine powder mixing.

Claims (2)

1. proctitis capsule, it is characterized in that: the raw material by following parts by weight is processed: phenolphthalein 1.25-2.5 part, vitamin B1 1-2 part, metronidazole 5-10 part, 50 parts of Radix Et Rhizoma Rhei, 50 parts of Cortex Cinnamomis.
2. proctitis capsule according to claim 1 is characterized in that: the raw material by following parts by weight is processed: 2.5 parts of phenolphthaleins, 2 parts of vitamin B1s, 10 parts of metronidazoles, 50 parts of Radix Et Rhizoma Rhei, 50 parts of Cortex Cinnamomis.
CN2010102888508A 2010-09-21 2010-09-21 Capsule for treating rectitis Expired - Fee Related CN101933982B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102888508A CN101933982B (en) 2010-09-21 2010-09-21 Capsule for treating rectitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102888508A CN101933982B (en) 2010-09-21 2010-09-21 Capsule for treating rectitis

Publications (2)

Publication Number Publication Date
CN101933982A CN101933982A (en) 2011-01-05
CN101933982B true CN101933982B (en) 2012-04-04

Family

ID=43387703

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102888508A Expired - Fee Related CN101933982B (en) 2010-09-21 2010-09-21 Capsule for treating rectitis

Country Status (1)

Country Link
CN (1) CN101933982B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1168482C (en) * 2002-09-08 2004-09-29 许忠文 Chinese medicine composition for treating enteritis
CN101112606A (en) * 2007-07-30 2008-01-30 何伟 Chinese traditional medicine for treating enteritis
CN101468161A (en) * 2007-12-27 2009-07-01 吴伶 Pure medicinal formulation for treating constipation

Also Published As

Publication number Publication date
CN101933982A (en) 2011-01-05

Similar Documents

Publication Publication Date Title
CN101491572A (en) Medicine for treating calculus and preparation method thereof
CN102441081B (en) Medicament for treating gout and its preparation method
CN103055260A (en) Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof
CN102038829A (en) Medicament for treating gastritis and ulcers of stomachs and duodenums
CN102188685A (en) Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof
CN1239177C (en) Chinese herbal medicine for treating piles
CN101530516B (en) Chinese medicament for treating appendicitis
CN101933982B (en) Capsule for treating rectitis
CN100490865C (en) Kidney-nourishing gout-treating capsule
CN101023988B (en) Chinese medicine preparation for treating infant's diarrhea
CN103263598B (en) Chinese medicine preparation for treating peripheral facial paralysis diseases
CN102038930A (en) Medicament for treating protrusion of lumbar vertebral disc
CN1315509C (en) Medicine for curing pyogenic osteomyelitis and process for preparing the same
CN103393799B (en) A kind of Chinese medicine composition for the treatment of acquired immune deficiency syndrome (AIDS) and preparation method thereof
CN1179731C (en) Medicine for treating dental diseases
CN101904995A (en) Traditional Chinese medicine composite for treating biliary calculi
CN101890076B (en) Traditional Chinese medicine oral preparation for treating sores and ulcers
CN102397375A (en) Traditional Chinese medicine composition for treating gastrointestinal disease
CN101112602B (en) Medicine for treating pharyngitis and method for preparing the same
CN105031243B (en) A kind of tune fat clearing liver Chinese medicine preparation
CN105055844A (en) Traditional Chinese medicine preparation for treating chronic constipation
CN101791370B (en) Medicine for treating ulcer caused by cold stomach
CN102198244B (en) Medicament for treating gastric and duodenal ulcers, gastritis and other diseases and preparation method thereof
CN102688441B (en) Cardamun Chinese medicinal decoction for treating cough and preparation method
CN1204914C (en) Medicine for preventing and treating intestinal adhesion in abdominal operation, and preparing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120404

Termination date: 20120921